Trump admin. Pfizer agrees to pay $ 1.95B for 100M more vaccine doses


in great shape / A nurse in the UK holds a vial of the Pfizer-Biotech COVID-19 vaccine on 22 December 2020.

The federal government has reached a deal with drugmaker Pfizer to secure an additional 100 million doses of the Pfizer-BioNtech COVID-19 vaccine before the end of July, the company said today.

Under the terms of the new agreement, the government will pay $ 1.95 billion for the additional dose. Of the new vaccine doses, 70 million are due June 30, with the remaining 30 million due no later than July 31. The agreement provides US officials with the option to later order an additional 400 million doses of the vaccine.

Secretary of Health and Human Services Alex Azar said in a statement that the additional Pfizer vaccine “can give Americans even more confidence that we will have enough supplies to vaccinate every American who wants to by June 2021,” when 100 Millions of Americans are added The government has already agreed to purchase from Pfizer, as well as the recently approved modern vaccine.

Similarly, the government has ordered a total of 200 million doses of the modern vaccine, which is also now in use. Each vaccine requires each person to receive two doses, so a total dose of 400 million is enough to immunize approximately 200 million people.

Rocky road

Pfizer initially offered the additional dose in its first round of talks with the US government in July, The New York Times was the first to report. At the time, the feds agreed to an initial order of 100 million doses, but repeatedly refused to lock in an order for an additional 100 million to 500 million doses, “despite repeated warnings from Pfizer officials that the demand There may be too much supply. “

When US officials refused to make a commitment, Pfizer instead reached agreements with other countries to make vaccines. To reach a new deal with Pfizer to secure an additional 100 million doses in the first half of 2021, the government agreed to implement the Defense Production Act to provide the company access to exclusive supplies into production. Need to accelerate, the New York Times reported.

The Food and Drug Administration approved the right to emergency use for the Pfizer vaccine not long after on Friday, December 11, shipment of the vaccine to facilities across the country began almost immediately, and on the following Monday morning, health care workers The first vaccination was underway.

Shortly after the first wave of vaccines came out, however, delivery killed the bumps. More than a dozen states found they were receiving significantly lower doses than anticipated – half or less of the expected dose in the second week of vaccine delivery. The states, naturally, asked the Feds, and HHS’s Azar identified the “core issue” as “the ability to rapidly manufacture the vaccine” around the challenges of production.

However, Pfizer in a statement pointed fingers at the US federal government for sarcasm.

On December 17, the company stated, “Pfizer has no production issues with our COVID-19 vaccine, and no shipment containing the vaccine is on hold or delayed,” this week we successfully shipped all 2.9 million doses. To visit the places designated by the US government. We have millions more doses sitting in our warehouse, but, so far, we have not received any shipment instructions for additional doses. “

Leave a Reply

Your email address will not be published.